Leukemia risk factor ARID5B coordinates HDAC-mediated transcriptional repression
Nucleic Acids Research · 22.06.2026 · 54 (12)
DOI: 10.1093/nar/gkag628 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 22.06.2026. Verfasst von Ana P Kutschat und 8 weiteren Autor:innen. Beteiligte Einrichtung: St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Transcription Factors, Histone Deacetylase 1, Transcription, Genetic. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Leukemia Research Foundation, European Research Council.
Abstract (Originalsprache)
Multiple genetic association studies linked variants at ARID5B with predisposition to B-cell–derived acute lymphoblastic leukemia (B-ALL) in children. Still, the molecular function of ARID5B remains largely uncharacterized. Here, we employ a combination of proteomics, genomics, and transcriptomics to describe the molecular mechanisms of ARID5B. We identify that ARID5B interacts with MIER1, C16ORF87, HDAC1, and HDAC2 forming a chromatin repressor complex. By CUT&RUN, we mapped ARID5B binding in active regions of the genome, tethering HDAC1 and HDAC2 to distal regulatory elements and promoters. Genes actively repressed by the ARID5B repressor complex are involved in B-cell proliferation and B-cell–specific signaling. Together, we describe how ARID5B assembles into a repressor complex and regulates B-cell–specific processes. Understanding its molecular mechanism will help elucidating how noncoding germline variants at ARID5B predispose to B-ALL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.
- CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
- Medical University of Vienna, Institute of Artificial Intelligence, Center for Medical Data Science, 1090 Vienna, Austria.
- Center for Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.
ORCID-Profile: Ana P Kutschat, Fabian Frommelt, Gerlinde Karbon, Giulio Superti-Furga, Davide Seruggia
Förderung
- Austrian Science Fund
- Leukemia Research Foundation
- European Research Council
- Marie Skłodowska-Curie
- Austrian Academy of Sciences
- Marie Skłodowska–Curie
Zitieren
APA
Kutschat, A. P., Frommelt, F., Santini, B. L., Müller, S., Batty, P., Awasthi, A., Karbon, G., Superti-Furga, G., & Seruggia, D. (2026). Leukemia risk factor ARID5B coordinates HDAC-mediated transcriptional repression. Nucleic Acids Research, 54(12). https://doi.org/10.1093/nar/gkag628
Vancouver
Kutschat AP, Frommelt F, Santini BL, Müller S, Batty P, Awasthi A, et al. Leukemia risk factor ARID5B coordinates HDAC-mediated transcriptional repression. Nucleic Acids Research. 2026;54(12). doi:10.1093/nar/gkag628
BibTeX
@article{Kutschat2026,
author = {Kutschat, Ana P and Frommelt, Fabian and Santini, Brianda L and Müller, Sophie and Batty, Paul and Awasthi, Animesh and Karbon, Gerlinde and Superti-Furga, Giulio and Seruggia, Davide},
title = {Leukemia risk factor ARID5B coordinates HDAC-mediated transcriptional repression},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {12},
doi = {10.1093/nar/gkag628}
}
EUVIMED